Sickle cell breakthrough: World's first CRISPR therapy cures Louisiana man's lifelong disease
- A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world's first approved CRISPR-based gene-editing therapy.
- Daniel Cressy, from Metairie near New Orleans, had lived with the inherited blood disorder since childhood, enduring severe pain crises and repeated hospitalisations.
- After undergoing the pioneering treatment at Manning Family Children's Hospital, doctors confirmed he no longer showed signs of active sickle cell disease.
Unverified
- A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world's first approved CRISPR-based gene-editing therapy.
- Daniel Cressy, from Metairie near New Orleans, had lived with the inherited blood disorder since childhood, enduring severe pain crises and repeated hospitalisations.
- After undergoing the pioneering treatment at Manning Family Children's Hospital, doctors confirmed he no longer showed signs of active sickle cell disease.
Sources: Times of India